Editorials Balancing the benefits and harms of drug treatments for older men with lower urinary tract symptoms BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5608 (Published 27 October 2015) Cite this as: BMJ 2015;351:h5608 Article Related content Metrics Responses Peer review Related articles Research The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study Published: 26 October 2015; BMJ 351 doi:10.1136/bmj.h5398 Clinical Review Lower urinary tract symptoms in men Published: 14 August 2014; BMJ 349 doi:10.1136/bmj.g4474 ResearchThe risk of fall and fracture with the initiation of a prostate-selective α antagonist See more Prostate cancer: Could polygenic risk scores make national screening a reality? BMJ April 15, 2025, 389 r763; DOI: https://doi.org/10.1136/bmj.r763 NICE recommends “targeted” drug capivasertib for advanced breast cancer BMJ April 14, 2025, 389 r762; DOI: https://doi.org/10.1136/bmj.r762 Cancer: People in UK’s poorest areas have longer waits for care and higher death rates BMJ February 21, 2025, 388 r367; DOI: https://doi.org/10.1136/bmj.r367 Hospitals are urged to learn from case of delayed cancer diagnosis after failure to follow up BMJ February 06, 2025, 388 r264; DOI: https://doi.org/10.1136/bmj.r264 Calcium rich diet could reduce bowel cancer risk, study finds BMJ January 08, 2025, 388 r42; DOI: https://doi.org/10.1136/bmj.r42
